Active substance
Triamcinolone
- SFDA 6
- US FDA 171
- Health Canada 12
- US price lines 34
- NHS prices 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Epirelefan | 40 mg/ml | Suspension for injection · Intraarticular use | 1 Vial | SAR 17.90 | Generic · Prescription | EIPICO | Valid |
| KENACORT-A 40MG\ML INJ | 40 mg/ml | Suspension for injection · Intramuscular use | 1 Vial | SAR 25.60 | NCE · Prescription | BRISTOL-MYERS SQUIBB | Valid |
| Naselfast nasal spray suspension | 55 µg | Nasal spray · Nasal use | 1 Bottle | SAR 46.55 | NCE · OTC | Opella Healthcare UK Limited | Valid |
| VITREAL S OPHTHALMIC SUSPENSION | 4 % | Suspension · Ophthalmic use | 1 Vial | SAR 295.05 | Generic · Prescription | Fidia Farmaceutici S.p.A. | Valid |
| CINOKORT 40 MG - 2 ML AMPOULE | 20 mg/ml | Suspension for injection · Intramuscular use | 1 Ampoule | SAR 1.95 | NCE · Prescription | SHIFA PHARMACEUTICAL INDUSTRIES | Invalid · Not Marketed |
| KENALOG IN ORABASE (PASTE 0.1%) | 0.1 % | Oral paste · Oral use | 1 Tube | SAR 10.25 | NCE · Prescription | BRISTOL - MYERS SQUIBB /PFIZER EEIG | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ENTEROPATHIC ARTHROPATHIES, UNSPECIFIED SITE REACTIVE ARTHROPATHY, UNSPECIFIED; GOUT; INFANTILE HEMANGIOMA; JUVENILE IDIOPATHIC ARTHRITIS (JIA); LOW BACK PAIN; OSTEOARTHRITIS; PEMPHIGUS; PSORIATIC ARTHRITIS; RHEUMATOID ARITHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| KENALOG-10 | 10MG/ML | injectable · injection | APOTHECON | Prescription | 4 Jan 1960 |
| KENALOG-40 | 40MG/ML | injectable · injection | APOTHECON | Prescription | 1 Feb 1965 |
| KENALOG-80 | 80MG/ML | injectable · injection | APOTHECON | Prescription | 1 Feb 1965 |
| TRIAMCINOLONE ACETONIDE | 0.025%; 0.5%; 0.1% | ointment · topical | FOUGERA PHARMS | Prescription | 9 Mar 1978 |
| TRIAMCINOLONE ACETONIDE | 0.025%; 0.5%; 0.1% | cream · topical | FOUGERA PHARMS | Prescription | 9 Mar 1978 |
| TRIAMCINOLONE ACETONIDE | 0.5%; 0.025%; 0.1% | cream · topical | PADAGIS US | Prescription | 9 Apr 1981 |
| TRIAMCINOLONE ACETONIDE | 0.5%; 0.025%; 0.1% | ointment · topical | PADAGIS US | Prescription | 5 Nov 1981 |
| TRIDERM | 0.1%; 0.025%; 0.5% | cream · topical | CROWN LABS | Prescription | 19 Mar 1984 |
| TRIAMCINOLONE ACETONIDE | 0.025% | lotion · topical | PHARMOBEDIENT | Prescription | 1 Apr 1985 |
| TRIAMCINOLONE ACETONIDE | 0.1% | lotion · topical | PHARMOBEDIENT | Prescription | 3 Apr 1985 |
| TRIAMCINOLONE ACETONIDE | 0.1% | lotion · topical | COSETTE PHARMS NC | Prescription | 14 Aug 1986 |
| TRIAMCINOLONE ACETONIDE | 0.1% | paste · dental | SUN PHARMA CANADA | Prescription | 1 Oct 1986 |
| TRIAMCINOLONE ACETONIDE | 0.025% | ointment · topical | COSETTE PHARMS NC | Prescription | 23 Dec 1988 |
| TRIAMCINOLONE ACETONIDE | 0.1% | ointment · topical | COSETTE PHARMS NC | Prescription | 23 Dec 1988 |
| TRIAMCINOLONE ACETONIDE | 0.025% | cream · topical | COSETTE PHARMS NC | Prescription | 31 May 1991 |
| TRIAMCINOLONE ACETONIDE | 0.1% | cream · topical | COSETTE PHARMS NC | Prescription | 31 May 1991 |
| TRIAMCINOLONE ACETONIDE | 0.1% | ointment · topical | SUN PHARMA CANADA | Prescription | 30 Sep 1994 |
| NASACORT ALLERGY 24 HOUR | 0.055MG/SPRAY | spray, metered · nasal | CHATTEM SANOFI | Over-the-counter | 20 May 1996 |
| TRIAMCINOLONE ACETONIDE | 0.1% | cream · topical | TARO | Prescription | 26 Nov 1997 |
| TRIAMCINOLONE ACETONIDE | 0.025%; 0.1% | lotion · topical | FOUGERA PHARMS | Prescription | 21 Apr 2003 |
| TRIAMCINOLONE ACETONIDE | 0.025%; 0.1% | cream · topical | MICRO LABS | Prescription | 9 Jun 2006 |
| TRIAMCINOLONE ACETONIDE | 0.1% | lotion · topical | MICRO LABS | Prescription | 13 Dec 2006 |
| TRIESENCE | 40MG/ML (40MG/ML) | injectable · intravitreal | HARROW EYE | Prescription | 29 Nov 2007 |
| TRIESENCE | 40MGML | injectable · suspension | ALCON RES | Prescription | 29 Nov 2007 |
| TRIAMCINOLONE ACETONIDE | 0.055MG/SPRAY | spray, metered · nasal | PERRIGO PHARMA INTL | Over-the-counter | 30 Jul 2009 |
146 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-TRIAMCINOLONE AQ | 02437635 | 55 MCG / ACT | SPRAY (METERED-DOSE) · NASAL | APOTEX INC |
| ARISTOCORT C | 02194066 | 0.5 % / W/W | CREAM · TOPICAL | BAUSCH HEALTH, CANADA INC. |
| ARISTOCORT R | 02194031 | 0.1 % / W/W | OINTMENT · TOPICAL | BAUSCH HEALTH, CANADA INC. |
| ARISTOCORT R | 02194058 | 0.1 % / W/W | CREAM · TOPICAL | BAUSCH HEALTH, CANADA INC. |
| KENALOG-10 INJECTION | 01999761 | 10 MG / ML | SUSPENSION · INTRA-ARTICULAR; INTRASYNOVIAL; INTRADERMAL; INTRABURSAL | BRISTOL-MYERS SQUIBB CANADA |
| KENALOG-40 INJECTION | 01999869 | 40 MG / ML | SUSPENSION · INTRA-ARTICULAR; INTRAMUSCULAR | BRISTOL-MYERS SQUIBB CANADA |
| NASACORT ALLERGY 24HR | 02417510 | 55 MCG / ACT | SPRAY (METERED-DOSE) · NASAL | SANOFI CONSUMER HEALTH INC |
| NASACORT AQ | 02213834 | 55 MCG / ACT | SPRAY (METERED-DOSE) · NASAL | SANOFI CONSUMER HEALTH INC |
| ORACORT | 01964054 | 0.1 % | PASTE · DENTAL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| TRIADERM CRM 0.1% | 00716960 | 0.1 % | CREAM · TOPICAL | TARO PHARMACEUTICALS INC |
| TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | 01977563 | 40 MG / ML | SUSPENSION · INTRA-ARTICULAR; INTRAMUSCULAR | STERIMAX INC |
| TRIESENCE | 02368676 | 40 MG / ML | SUSPENSION · INTRAVITREAL | NOVARTIS PHARMACEUTICALS CANADA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | KENALOG-10 50 MG/5 ML VIAL | $2.3256 | per ML | 23 Sep 2026 |
| US NADAC | KENALOG-40 200 MG/5 ML VIAL | $9.1454 | per ML | 23 Sep 2026 |
| US NADAC | KENALOG-40 40 MG/ML VIAL | $9.00182 | per ML | 23 Sep 2026 |
| US NADAC | KENALOG-40 400 MG/10 ML VIAL | $6.78651 | per ML | 23 Sep 2026 |
| US NADAC | KENALOG-80 80 MG/ML VIAL | $17.86667 | per ML | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% CREAM | $0.1198 | per GM | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% CREAM | $0.0532 | per GM | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% CREAM | $0.03528 | per GM | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% LOTION | $0.35034 | per ML | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% OINT | $0.07404 | per GM | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% OINT | $0.23917 | per GM | 23 Sep 2026 |
| US NADAC | TRIAMCINOLONE 0.025% OINT | $0.04715 | per GM | 23 Sep 2026 |
| NHS Drug Tariff | Triamcinolone 55micrograms/dose nasal spray | £7.39 | 120 dose | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 5 Jun 2024 KENALOG-10 — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 5 Jun 2024 KENALOG-40 — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 2 Dec 2020 ZILRETTA — safety-related labeling change
Labeling sections changed: Adverse Reactions - EMA PRAC 9 Jan 2014 PRAC signal: Postmenopausal haemorrhage
Action for MAH: update of the product information: Yes - EMA PRAC 5 Sep 2013 PRAC signal: Postmenopausal haemorrhage
Action for MAH: update of the product information: No
Combinations containing Triamcinolone
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.